Stock DYAX CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Dyax Corp.

Equities

US26746E1038

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Dyax Corp.
2015 Baxalta : Exclusive: Shire prepares to make new bid for Baxalta - source RE
2015 Wall St. climbs, led by energy, healthcare; Nasdaq 100 hits 15-year high RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Dyax : Shire Completes Acquisition of Dyax
PR
Dyax : Sets January 21, 2016 As Date of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Shire plc
BU
Dyax : Presents DX-4012 Data at the 2015 American Society of Hematology Annual Meeting
PU
Dyax : Announces Early Termination of Hart-Scott-Rodino Waiting Period
PU
Dyax : Recognized as a "Top Place to Work" by The Boston Globe for Second Year in a Row
PU
Dyax : Presents Phase 1b DX-2930 Data at the American College of Allergy, Asthma, and Immunology Annual Meeting
PU
Dyax : Presents DX-4012 Data at the 2015 American Society of Hematology Annual Meeting
BU
Dyax : Announces Early Termination of Hart-Scott-Rodino Waiting Period
BU
Baxalta : Exclusive: Shire prepares to make new bid for Baxalta - source
RE
Dyax : Recognized as a “Top Place to Work” by The Boston Globe for Second Year in a Row
BU
Dyax : Presents Phase 1b DX-2930 Data at the American College of Allergy, Asthma, and Immunology Annual Meeting
BU
Dyax : Brower Piven Commences An Investigation Into The Proposed Sale Of Dyax Corp. And Encourages Investors To Contact The Firm For Additional Information
BU
Dyax : Brower Piven Commences An Investigation Into The Proposed Sale Of Dyax Corp. And Encourages Investors To Contact The Firm For Additional Information
BU
Dyax : Ryan & Maniskas, LLP : Announces Investigation of Dyax Corp.
PR
Wall St. climbs, led by energy, healthcare; Nasdaq 100 hits 15-year high
RE
Baxalta : Shire to buy Dyax for $5.9 billion, still wants Baxalta
RE
Baxalta : Shire to buy Dyax for $5.9 billion, still wants Baxalta
RE
Dyax : Announces Cancellation of Research and Development Day
BU
Dyax : Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
PR
Dyax : Announces Third Quarter 2015 Financial Results
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Dyax Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW